Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
$0.65
$0.03
$2.09
$857K0.22524,054 shs53.64 million shs
Horiba Ltd. stock logo
HRIBF
Horiba
$61.03
$61.03
$49.06
$100.67
$2.56B0.24N/AN/A
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$1.24
-3.9%
$1.12
$0.85
$2.72
$372.10M2.19.75 million shs11.66 million shs
Quanterix Corporation stock logo
QTRX
Quanterix
$6.65
$5.55
$4.05
$16.74
$332.19M1.05602,441 shs487,585 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
0.00%0.00%0.00%-94.22%-96.54%
Horiba Ltd. stock logo
HRIBF
Horiba
0.00%0.00%0.00%0.00%-19.02%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
0.00%+1.57%+30.63%+9.32%-5.84%
Quanterix Corporation stock logo
QTRX
Quanterix
0.00%+8.66%+29.63%+2.15%-49.66%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
N/AN/AN/AN/AN/AN/AN/AN/A
Horiba Ltd. stock logo
HRIBF
Horiba
N/AN/AN/AN/AN/AN/AN/AN/A
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
2.1379 of 5 stars
3.23.00.00.01.70.01.3
Quanterix Corporation stock logo
QTRX
Quanterix
2.5092 of 5 stars
3.31.00.00.02.83.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
4.00
Strong BuyN/AN/A
Horiba Ltd. stock logo
HRIBF
Horiba
0.00
N/AN/AN/A
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
2.44
Hold$2.0666.22% Upside
Quanterix Corporation stock logo
QTRX
Quanterix
2.50
Moderate Buy$15.60134.59% Upside

Current Analyst Ratings Breakdown

Latest HRIBF, AXDX, PACB, and QTRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/25/2025
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$2.00 ➝ $1.50
5/15/2025
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$2.00 ➝ $1.25
5/15/2025
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$1.80 ➝ $1.80
5/13/2025
Quanterix Corporation stock logo
QTRX
Quanterix
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
4/30/2025
Quanterix Corporation stock logo
QTRX
Quanterix
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/30/2025
Quanterix Corporation stock logo
QTRX
Quanterix
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform$12.00 ➝ $8.00
4/10/2025
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$3.00 ➝ $3.00
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
$11.70M0.00N/AN/A($1.37) per share0.00
Horiba Ltd. stock logo
HRIBF
Horiba
$2.10B1.22$7.56 per share8.07$49.51 per share1.23
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$154.01M2.42N/AN/A$1.85 per share0.67
Quanterix Corporation stock logo
QTRX
Quanterix
$133.92M2.48N/AN/A$8.57 per share0.78
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
-$61.62M-$2.34N/AN/AN/A-471.83%N/A-191.66%N/A
Horiba Ltd. stock logo
HRIBF
Horiba
$221.71M$5.4011.30N/A10.87%11.94%7.76%8/6/2025 (Estimated)
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$309.85M-$2.79N/AN/AN/A-430.93%-52.07%-15.82%8/6/2025 (Estimated)
Quanterix Corporation stock logo
QTRX
Quanterix
-$38.53M-$1.30N/AN/AN/A-36.82%-15.07%-12.26%8/6/2025 (Estimated)

Latest HRIBF, AXDX, PACB, and QTRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2025Q1 2025
Quanterix Corporation stock logo
QTRX
Quanterix
-$0.69-$0.53+$0.16-$0.53$28.27 million$30.33 million
5/8/2025Q1 2025
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$0.19-$0.15+$0.04-$1.44$36.90 million$37.15 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
N/AN/AN/AN/AN/A
Horiba Ltd. stock logo
HRIBF
Horiba
N/AN/AN/AN/AN/A
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/AN/AN/AN/AN/A
Quanterix Corporation stock logo
QTRX
Quanterix
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
N/A
1.50
1.34
Horiba Ltd. stock logo
HRIBF
Horiba
0.18
3.36
2.38
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
7.05
6.68
5.87
Quanterix Corporation stock logo
QTRX
Quanterix
N/A
8.29
7.53

Institutional Ownership

CompanyInstitutional Ownership
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
17.14%
Horiba Ltd. stock logo
HRIBF
Horiba
N/A
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/A
Quanterix Corporation stock logo
QTRX
Quanterix
86.48%

Insider Ownership

CompanyInsider Ownership
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
43.60%
Horiba Ltd. stock logo
HRIBF
Horiba
N/A
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
2.40%
Quanterix Corporation stock logo
QTRX
Quanterix
6.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
22025.21 million14.13 millionOptionable
Horiba Ltd. stock logo
HRIBF
Horiba
8,95541.95 millionN/ANot Optionable
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
730300.08 million292.88 millionOptionable
Quanterix Corporation stock logo
QTRX
Quanterix
46049.95 million46.51 millionOptionable

Recent News About These Companies

Insider Spends US$1.1m Buying More Shares In Quanterix
Quanterix: Hard To Make A Good Diagnosis

New MarketBeat Followers Over Time

Media Sentiment Over Time

Accelerate Diagnostics stock logo

Accelerate Diagnostics NASDAQ:AXDX

$0.04 +0.04 (+∞)
As of 05/14/2025
This is a fair market value price provided by Polygon.io. Learn more.

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

Horiba stock logo

Horiba OTCMKTS:HRIBF

$61.03 0.00 (0.00%)
As of 06/27/2025

HORIBA, Ltd. manufactures and sells instruments and systems worldwide. The company operates in five segments: Automotive, Environment/Process, Medical, Semiconductor, and Scientific. The Automotive segment offers engine emission measurement devices; in-use vehicle emission measurement devices; on-board emission measurement devices; in-vehicle exhaust gas measuring devices; driveline test systems; engine test systems; brake test systems; fuel cell test devices; battery test devices; and vehicle development engineering and test engineering services, as well as leases and manages research and development facilities. The Environment/Process segment provides flue gas analyzers, water quality measuring devices, air pollution monitoring analyzers, environmental radiation measuring instruments, and process measurement equipment. The Medical segment offers hematology and CRP, immunology, clinical chemistry, and blood glucose analyzers, blood cell counters, biochemical testing devices, blood glucose testing devices, as well as coagulation/hemostasis analyzers. The Semiconductor segment provides mass flow controllers, chemical concentration monitors, semiconductor contaminant inspection equipment, and residual gas analyzer. The Scientific segment offers Raman spectrometers, pH meters, water quality measuring devices, particle size distribution measuring devices, X -ray fluorescence analyzers, elemental analyzers, fluorescence spectroscopy/lifetime measurement devices, spectrometer/detectors, and gratings. It also engages in the fund management, software development, and automation software for engine. The company's products are used in arts, entertainment, and recreation; education, research and development, and government institution; food and beverage; energy and environment; health care; industrials; information technology; water; materials; mobility and transport; and waste management applications. HORIBA, Ltd. was founded in 1945 and is headquartered in Kyoto, Japan.

Pacific Biosciences of California stock logo

Pacific Biosciences of California NASDAQ:PACB

$1.24 -0.05 (-3.88%)
As of 04:00 PM Eastern

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Quanterix stock logo

Quanterix NASDAQ:QTRX

$6.65 0.00 (0.00%)
As of 04:00 PM Eastern

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.